Literature DB >> 19138929

Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention.

Peter Lance1, Stanley R Hamilton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19138929     DOI： 10.1158/1940-6207.CAPR-08-0043

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN： 1940-6215


× No keyword cloud information.
  7 in total

1.  HD chromoendoscopy coupled with DNA mass spectrometry profiling identifies somatic mutations in microdissected human proximal aberrant crypt foci.

Authors:  David A Drew; Thomas J Devers; Michael J O'Brien; Nicole A Horelik; Joel Levine; Daniel W Rosenberg
Journal:  Mol Cancer Res       Date:  2014-03-20       Impact factor: 5.852

Review 2.  Chemoprevention of Colorectal Cancer.

Authors:  Bryson W Katona; Jennifer M Weiss
Journal:  Gastroenterology       Date:  2019-09-26       Impact factor: 22.682

3.  Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention.

Authors:  Paul J Limburg; Michelle R Mahoney; Katie L Allen Ziegler; Stephen J Sontag; Robert E Schoen; Richard Benya; Michael J Lawson; David S Weinberg; Elena Stoffel; Michael Chiorean; Russell Heigh; Joel Levine; Gary Della'Zanna; Luz Rodriguez; Ellen Richmond; Christopher Gostout; Sumithra J Mandrekar; Thomas C Smyrk
Journal:  Cancer Prev Res (Phila)       Date:  2011-01-05

4.  One year recurrence of aberrant crypt foci.

Authors:  Paul F Pinsky; James Fleshman; Matt Mutch; Christopher Rall; Aline Charabaty; David Seligson; Sarah Dry; Asad Umar; Robert E Schoen
Journal:  Cancer Prev Res (Phila)       Date:  2010-06-22

5.  Aberrant crypt foci: the case for inclusion as a biomarker for colon cancer.

Authors:  Michael J Wargovich; Vondina R Brown; Jay Morris
Journal:  Cancers (Basel)       Date:  2010-09-16       Impact factor: 6.639

Review 6.  Colon preneoplastic lesions in animal models.

Authors:  Masumi Suzui; Takamitsu Morioka; Naoki Yoshimi
Journal:  J Toxicol Pathol       Date:  2013-12-26       Impact factor: 1.628

7.  Dietary Polyacetylenic Oxylipins Falcarinol and Falcarindiol Prevent Inflammation and Colorectal Neoplastic Transformation: A Mechanistic and Dose-Response Study in A Rat Model.

Authors:  Morten Kobaek-Larsen; Gunnar Baatrup; Martine KhataeiNotabi; Rime Bahij El-Houri; Emma Pipó-Ollé; Eva Christensen Arnspang; Lars Porskjær Christensen
Journal:  Nutrients       Date:  2019-09-14       Impact factor: 5.717
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.